Table 2.
Characteristics of included studies
| First author | Year | Country | Sample size | Tumor site | TNM stage | Reference standard | Nodal metastasis a | Genes | Method | Tissue | Cutoff | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene amplification | Hanken | 2014 | Germany | 255 | Oral cavity | All | pN | 46 % | CCND1 | FISH | FFPE | G/C ratio >2.0 |
| Yoshioka | 2013 | Japan | 25 | Oral cavity | All | pN | 60 % | 11q13.3 | CGH | FFPE | G/C ratio >1.12 | |
| Sugahara | 2011 | Japan | 54 | Oral cavity | All | pN | 41 % | 11 genes in 11q13c | CGH | Fresh frozen | G/C ratio >1.5 in ≥3 genes | |
| Pathare | 2011 | India | 97 | Oral cavity | N.A. | pN | 56 % | 11q13 | CGH | Fresh frozen | G/C ratio >1.25 | |
| Michikawa | 2011 | Japan | 127 | Oral cavity | All | pN | 42 % | CCND1 | FISH | Fixed FNA | G/C ratio >1.2 and gene/cell ratio >3 | |
| Mahdey | 2011 | Malaysia | 50 | Cheek and tongue | All | pN | 54 % | CCND1 | FISH | FFPE | G/C Ratio >2.0 | |
| Prapinjumruneb | 2010 | Japan | 60 | Tongue | T1-2 | pN or FU | 43 % | FADD | RT-PCR | FFPE | G/C ratio >1.5 | |
| Myo | 2005 | Japan | 45 | Oral cavity | cT1-2N0 | pN or FU | 38 % | CCND1 | FISH | Fixed FNA | >20 % of 100 cells ≥3 spots | |
| Fujii | 2001 | Japan | 23 | Tongue | All | pN or FU | 61 % | CCND1 | FISH | FFPE | >20 % of 100 cells ≥3 spots | |
| Protein overexpression | Huang | 2012 | Taiwan | 264 | Oral cavity | All | pN | 48 % | CCND1 | IHC | FFPE | 10 % staining |
| Prapinjumrune b | 2010 | Japan | 60 | Tongue | T1-2 | pN or FU | 40 % | FADD | IHC | FFPE | 29.2 % staining | |
| Shah | 2009 | India | 135 | Cheek and tongue | All | pN | 33 % | CCND1 | IHC | FFPE | 10 % staining | |
| Maahs | 2007 | Brazil | 45 | Oral cavity | All | pN | 51 % | CCND1 | IHC | FFPE | 1 % staining | |
| Rodolico | 2005 | Italy | 97 | Lower lip | Any T cN0 | pN | 13 % | CCND1 | IHC | FFPE | 1 % staining | |
| Miyamoto b | 2003 | Japan | 41 | Oral cavity | All | pN | 20 % | CCND1 | IHC | FFPE | 10 % staining | |
| Takes | 2002 | Netherlands | 52 | Oral cavity | All | pN | 63 % | CCND1 | IHC | FFPE | 5 % staining | |
| Goto | 2002 | Japan | 41 | Tongue | cT1-2 | pN | 44 % | CCND1 | IHC | FFPE | 33 % staining | |
| Kuo | 1999 | Taiwan | 88 | Oral cavity | All | pN | 60 % | CCND1 | IHC | FFPE | 10 % staining | |
| Bova | 1999 | Australia | 147 | Tongue | All | pN | 23 % | CCND1 | IHC | FFPE | 10 % staining |
TNM tumor-node-metastasis, FISH fluorescence in situ hybridization, CGH comparative genomic hybridization, IHC immunohistochemistry, FFPE formalin-fixed paraffin-embedded, FNA fine needle aspiration, G/C gene/chromosome
aHistologically proven nodal metastasis
bThese studies correlated both gene amplification and protein overexpression with nodal metastasis
cTPCN2, MYEOV, CCND1, ORAOV1, FGF4, TMEM16A, FADD, PPFIA1, CTTN, SHANK2, DHCR7